EI
DMK

EAM Investors’s DMK Pharmaceuticals Corporation Common Stock DMK Stock Holding History

EAM Investors’s Portfolio DMK Stock Details DMK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-5,310
Closed -$1.94M – 362
2017
Q3 		$1.94M Buy
5,310
+1,956
+58% +$694K 0.26% 204
2017
Q2 		$1.22M Buy
+3,354
New +$1M 0.2% 185

Other funds holding DMK

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BRF
B. Riley Financial Los Angeles, California $456M AUM 896.07% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BA
Bard Associates Chicago, Illinois $398M AUM 54.32% 1-Year Est. Return
LCM
Leisure Capital Management Costa Mesa, California $286M AUM 26.75% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

EAM Investors's DMK Position: Q4 2017 in Review

EAM Investors sold out of DMK Pharmaceuticals Corporation Common Stock (DMK) in Q4 2017, closing a stake of 5,310 shares — an estimated $1.94M sold.

EAM Investors first reported a position in DMK in Q2 2017 and held it in 2 quarters. The position peaked at $1.94M in Q3 2017. 58 funds tracked by Wall St. Rank hold DMK as of Q4 2017.

  • EAM Investors reported no remaining DMK Pharmaceuticals Corporation Common Stock position as of Q4 2017 after selling out during the quarter.
  • EAM Investors sold 5,310 DMK Pharmaceuticals Corporation Common Stock shares in Q4 2017, an estimated $1.94M.
  • EAM Investors first reported a position in DMK Pharmaceuticals Corporation Common Stock in Q2 2017 and held it in 2 quarters.
  • EAM Investors's DMK Pharmaceuticals Corporation Common Stock position peaked at $1.94M in Q3 2017.
  • 58 funds tracked by Wall St. Rank held DMK Pharmaceuticals Corporation Common Stock as of Q4 2017.

Based on EAM Investors's 13F filing for Q4 2017, filed 12 Feb 2018.